Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- dor torácica
- diaforese
- choque cardiogênico
- insuficiência cardíaca aguda
Outros fatores diagnósticos
- náuseas e vômitos
- dor epigástrica
- arritmias
- bulhas cardíacas anormais
- dispneia
- síncope
- aparecimento no começo da manhã
Fatores de risco
- tabagismo
- hipertensão
- diabetes
- obesidade e fenótipo de síndrome metabólica
- comportamento sedentário e inatividade física
- dislipidemia
- doença renal crônica (DRC)
- aterosclerose (história de angina, infarto do miocárdio, AVC, ataque isquêmico transitório, doença vascular periférica)
- história familiar de doença arterial coronariana (DAC) prematura
- idade >60 anos
- uso de cocaína
- depressão
- trombose de stent ou reestenose
- apneia do sono
- procedimentos cirúrgicos (incluindo os períodos intraoperatório e pós-operatório)
- enxaqueca
- desfechos adversos da gestação
- carga anticolinérgica
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- eletrocardiograma (ECG)
- biomarcadores cardíacos
- ecocardiografia
- radiografia torácica
- Hemograma completo
- ureia e creatinina sérica
- eletrólitos
- TFHs
- glicose sanguínea
- proteína C-reativa
Investigações a serem consideradas
- angiografia/cateterismo cardíaco
- lipídios
- peptídeo natriurético do tipo B (PNB) ou pró-peptídeo natriurético do tipo B N-terminal (NT-proPNB)
- teste ergométrico
- angiotomografia coronária (ATC)
Algoritmo de tratamento
Colaboradores
Autores
Mahi L. Ashwath, MD, MBA, FACC, FASE, FSCMR
Professor of Medicine and Radiology
Multimodality Imaging Director
Inaugural Reuben Jacobs Chair in Internal Medicine
UHS/UT Heart and Vascular Institute
San Antonio
TX
Declarações
MLA declares that she is a consultant for Tersera.
Agradecimentos
Dr Mahi L. Ashwath would like to gratefully acknowledge Dr Sanjay Gandhi, Dr Cody Deen, Dr Sripal Bangalore, Dr Mina Owlia, Dr Thomas Vanhecke, and Dr Dena Krishnan, the previous contributors to this topic.
Declarações
SG declares that he is Senior Director of Medical Strategy and Innovation for the US market at Philips. SG is a senior advisor at Emeritus. SG is a voluntary board member of the American College of Cardiology (ACC) National Cardiovascular Data Registry oversight committee, the Chest Pain Myocardial Infarction registry steering committee, and the ACC finance committee. CSD was previously the Director of Cardiac Rehab for Chatham Hospital, which was financially set up as a consultancy relationship, until 2017. CSD has spoken (unpaid) at the Update in Cardiology and Update in Internal Medicine Conferences at UNC for the last 5 years. CSD has served as the PI for the Dal-GeneE (site now closed) and the ACCELERATE Trials at the University of North Carolina (trial now completed). Each trial required paid travel to an investigator meeting. SB, MO, TV, and DK declare that they have no competing interests.
Revisores
Syed Wamique Yusuf, MBBS, FRCPI
Professor of Medicine
Department of Cardiology
University of Texas
MD Anderson Cancer Center
Houston
TX
Declarações
SWY declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr;151(13):e771-862.Texto completo Resumo
Thygesen K, Alpert JS, Jaffe AS, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018 Oct 30;72(18):2231-64.Texto completo Resumo
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-826.Texto completo
Writing Committee Members; Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee On Clinical Practice Guidelines. J Am Coll Cardiol. 2021 Nov 30;78(22):e187-285.Texto completo Resumo
Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64(24):e139-228.Texto completo Resumo
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee On Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e18-114.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
Diretrizes
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes
Calculadoras
ASCVD Risk Estimator Plus Opens in new window
Mais Calculadoras
O uso deste conteúdo está sujeito ao nosso aviso legal